Anti-Human Papillomavirus 16 E7 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E7 T Cell Receptors Cyprus15729004.0Filed on 2015-05-29
Anti-Human Papillomavirus 16 E7 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E7 T Cell Receptors Switzerland15729004.0Filed on 2015-05-29
Anti-Human Papillomavirus 16 E7 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E7 T Cell Receptors Bulgaria15729004.0Filed on 2015-05-29
Anti-Human Papillomavirus 16 E7 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E7 T Cell Receptors Belgium15729004.0Filed on 2015-05-29
Anti-Human Papillomavirus 16 E7 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E7 T Cell Receptors Austria15729004.0Filed on 2015-05-29
Anti-Human Papillomavirus 16 E7 T Cell Receptors Read more about Anti-Human Papillomavirus 16 E7 T Cell Receptors Albania15729004.0Filed on 2015-05-29
ANTI-CD276 CHIMERIC ANTIGEN RECEPTORS Read more about ANTI-CD276 CHIMERIC ANTIGEN RECEPTORS US Application 16/788,895Filed on 2020-02-12
Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Read more about Method Of Treating Urothelial And Other Genitourinary Carcinomas Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Hong Kong62020002296.5Filed on 2017-09-27
PCSK9 VACCINE AND METHODS OF USING THE SAME Read more about PCSK9 VACCINE AND METHODS OF USING THE SAME United Kingdom15708062.3Filed on 2015-02-11
PCSK9 VACCINE AND METHODS OF USING THE SAME Read more about PCSK9 VACCINE AND METHODS OF USING THE SAME France15708062.3Filed on 2015-02-11